News
Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.
The 50-year-old is now on Novo Nordisk ’s Wegovy, but worries because it is less effective. Studies have shown Wegovy helps people lose less weight, on average, than Zepbound.
Wegovy’s primary purpose is a weight-loss medication, while Ozempic can improve blood sugar in those living with type 2 diabetes in addition to weight loss, Megan Warnke, RDN, CDCES, tells us.
When Wegovy gained Food and Drug Administration approval for weight loss in 2021 as a weekly injectable, prescriptions soared, reaching nearly 121,000 scripts in 2023, the study said.
Novo Nordisk has launched its wildly popular weight-loss drug Wegovy in more than 15 countries since 2021 at prices ranging from $200 to almost $2,000 a month, as Eli Lilly also began selling its ...
Wegovy treated a serious form of liver disease in a major clinical trial The Phase 3 clinical trial found that Wegovy reduced inflammation and scarring in people with metabolic dysfunction ...
In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.
Those who took Zepbound lost on average of 50 pounds, compared to 33 pounds lost among those who took Wegovy. That’s the equivalent of losing 20% of body weight with Zepbound, versus nearly 14% ...
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke, or heart disease-related death by 20% in a major clinical trial in people with cardiovascular disease, the first ...
While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback